PAR4 deficiency is cardioprotective after acute myocardial ischemia reperfusion injury.
PAR4 deletion reduces inflammation after acute ischemia reperfusion injury.
PAR4 mediates thrombin-induced myocyte apoptosis in vitro.
PAR4 induces myocyte apoptosis through activation of the JNK pathway.